English | Español

Amgen Inc.
Robert Hadley | Apr 16, 2017

XGEVA pending approval for myeloma patients
Erianne Leatherman | Apr 9, 2017

Amgen’s BLINCYTO to receive priority review from FDA
Erianne Leatherman | Apr 7, 2017

Repatha shows no memory effects while lowering LDL levels, study finds
Robert Hadley | Mar 28, 2017

European Commission approves Amgen's new anti-inflammatory drug
Robert Hadley | Mar 22, 2017

Amgen’s Repatha may help patients with tough cases of high cholesterol
Robert Hadley | Mar 17, 2017

Clinical trial shows immunotherapy can extend leukemia patients' life expectancy
Mark Iandolo | Oct 24, 2016

Amgen announces study regarding its XGEVA product
Amanda Rupp | Oct 3, 2016

Amgen to present new data concerning melanoma, metastatic colorectal cancer treatments

Trending
Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
Patient Daily | Aug 21, 2025

Otolaryngologist on sinusitis and tooth pain: ‘Inflammation in the bottom of the sinus can cause sensitivity in the teeth’
+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program